Zevra Therapeutics Inc (ZVRA)
5.21
+0.05
(+0.97%)
USD |
NASDAQ |
May 07, 14:05
Zevra Therapeutics Shareholders Equity (Quarterly): 61.86M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 61.86M |
| September 30, 2023 | 67.47M |
| June 30, 2023 | 68.50M |
| March 31, 2023 | 71.40M |
| December 31, 2022 | 75.12M |
| September 30, 2022 | 93.79M |
| June 30, 2022 | 99.23M |
| March 31, 2022 | 121.50M |
| December 31, 2021 | 127.12M |
| September 30, 2021 | 131.74M |
| June 30, 2021 | 130.66M |
| March 31, 2021 | 84.25M |
| December 31, 2020 | -66.41M |
| September 30, 2020 | -62.33M |
| June 30, 2020 | -62.86M |
| March 31, 2020 | -68.68M |
| December 31, 2019 | -74.46M |
| September 30, 2019 | -70.62M |
| June 30, 2019 | -81.55M |
| Date | Value |
|---|---|
| March 31, 2019 | -74.84M |
| December 31, 2018 | -66.57M |
| September 30, 2018 | -95.34M |
| June 30, 2018 | -83.54M |
| March 31, 2018 | -79.68M |
| December 31, 2017 | -57.52M |
| September 30, 2017 | -48.10M |
| June 30, 2017 | -39.28M |
| March 31, 2017 | -33.93M |
| December 31, 2016 | -18.70M |
| September 30, 2016 | -9.802M |
| June 30, 2016 | 0.333M |
| March 31, 2016 | -11.48M |
| December 31, 2015 | -10.12M |
| September 30, 2015 | -5.746M |
| June 30, 2015 | 3.463M |
| March 31, 2015 | -54.35M |
| December 31, 2014 | -48.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-81.55M
Minimum
Jun 2019
131.74M
Maximum
Sep 2021
33.99M
Average
68.50M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| OptiNose Inc | -86.61M |
| Perspective Therapeutics Inc | 75.18M |
| Dare Bioscience Inc | -5.048M |
| Kodiak Sciences Inc | 265.78M |
| INmune Bio Inc | 38.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.33M |
| Total Liabilities (Quarterly) | 110.46M |
| Debt to Equity Ratio | 0.6913 |
| Current Ratio | 1.179 |
| Net Debt Paydown Yield | -2.20% |